These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9667723)

  • 1. Resistance to unfractionated heparin in the ICU: evaluation and management options.
    Levy JH; Frere C; Koster A
    Intensive Care Med; 2023 Aug; 49(8):1005-1007. PubMed ID: 37278759
    [No Abstract]   [Full Text] [Related]  

  • 2. COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No.
    Jimenez D; Rali P; Doerschug K
    Chest; 2022 Jun; 161(6):1448-1451. PubMed ID: 35550714
    [No Abstract]   [Full Text] [Related]  

  • 3. POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes.
    Tritschler T; Le Gal G; Brosnahan S; Carrier M
    Chest; 2022 Jun; 161(6):1446-1448. PubMed ID: 35469670
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Koch A; Bouges S; Ziegler S; Dinkel H; Daures JP; Victor N
    Br J Surg; 1997 Jun; 84(6):750-9. PubMed ID: 9189079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 6. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis].
    Daures JP; Schved JF; Momas I; Gril JC; Azoulay P; Gremy F
    Rev Epidemiol Sante Publique; 1989; 37(4):363-9. PubMed ID: 2558404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.